Spruce Biosciences Director in Stock Option Repricing Transaction
SPRUCE BIOSCIENCES, INC.
Subscribe to track SPRB
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Spruce Biosciences Director in Stock Option Repricing
Company: SPRUCE BIOSCIENCES, INC. (SPRB) Form: 4 | Filed: 2025/12/15 Significance: Low
Insider: Barretto-Ko Percival Title: Director
Transaction: • Type: Option Repricing • Shares: 800 options exchanged • Value: $0.00 • Owned After: 800 options
Key Insight: This is a non-cash administrative action. An old option for 800 shares with an exercise price of $169.50 was cancelled and replaced with a new option for 800 shares with a lower exercise price of $104.13. This is not an open market buy or sell.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: SPRUCE BIOSCIENCES, INC. (SPRB)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director participated in a company-wide stock option repricing, exchanging 800 old options for 800 new ones with a lower exercise price of $104.13.
- Market Impact: Neutral. This is a non-cash, administrative transaction with no immediate market impact or change in insider capital at risk.
Company Information
| Field | Value |
|---|---|
| Company | SPRUCE BIOSCIENCES, INC. |
| Ticker Symbol | SPRB |
| CIK | 0001683553 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Barretto-Ko Percival |
| CIK | 0001978654 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-11 |
| Transaction Code | A / D |
| Security Type | Stock Option (Right to Buy) |
| Shares Involved | 800 (Exchanged) |
| Price Per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 800 (Options) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 800 (Options) |
| % of Shares Outstanding | Not available |
| Post-Transaction Ownership | 800 options |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has no monetary value and therefore has a 0% impact on the company's $0.11 billion market capitalization.
- Ownership Concentration: The transaction does not change the number of underlying shares the insider has a right to acquire; it only adjusts the exercise price. It does not affect ownership concentration.
- Transaction Significance: The transaction is a stock option repricing, a common practice for companies whose stock price has declined, intended to re-incentivize employees and directors. It is an administrative change with no capital outlay from the insider and is considered low significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-cash, non-market transaction that exchanges one derivative security for another. It does not signal new insider sentiment or involve any capital investment.
Volume & Sentiment
- Expected Volume Impact: None. The transaction occurred off-market.
- Sentiment Indicator: Neutral. While option repricings can be viewed negatively by some investors as they re-price incentives after poor stock performance, this single, small transaction is unlikely to influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The filing explicitly states this was part of a "one-time stock option repricing" program. The old option with an exercise price of $169.50 was disposed of (Code D) and a new option with an exercise price of $104.13 was acquired (Code A). The number of shares and vesting schedule remained unchanged.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
